Clinical Welfare
Public Welfare
Clinical Apply
News
New Release
Infectious disease
Hematology / Oncology
NonInfectious disease
Male Health
Abyrone(abiraterone) is a synthetic, steroidal CYP17A1 inhibitor and the active metabolite of abiraterone acetate, an ester and prodrug of abiraterone that is used in the treatment of prostate cancer.